内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Reich Kristian. Officer active across 1 company, notably MoonLake Immunotherapeutics. Cumulatively, 14 filings have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €6.3m. Activity tracked since 14 February 2024. The latest transaction was filed on 27 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Reich Kristian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
1,100 股@ US$20.00Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-082804:0
50,000 股@ US$20.020.060% mcap7.8% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-080869:0
2,448 股@ US$20.000.0029% mcap0.4% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-080869:1
43,700 股@ US$20.090.053% mcap7.4% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-080133:0
16,105 股@ US$20.010.020% mcap2.9% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-079376:0
35,389 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-124516:0
130,000 股@ US$15.0839.2% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-120105:0
48,978 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-084492:0
111,949 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-005686:0
29,491 股@ US$55.0057.3% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-24-018671:0
10,000 股@ US$57.4520.4% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-24-016240:0
10,000 股@ US$62.4222.3% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-24-014996:0
2,527,477 股Class A ordinary shares, par value $0.0001 per shareSEC:0001013762-23-001295:0
500,006 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-23-028293:0
About Reich Kristian
Reich Kristian is a declarant linked to MoonLake Immunotherapeutics, where he is Chief Scientific Officer. He has 6 filings in total, and among the sampled recent filings from 2023-04-07 to 2025-01-22, sales total 2610844 EUR, with notable sales on 2024-02-29 for 1494807.328055616 EUR, on 2024-02-16 for 582877.9362780036 EUR, and on 2024-02-22 for 533159.0190039712 EUR.